TRAW
Price:
$0.8503
Market Cap:
$7.77M
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is pre...[Read more]
Industry
Biotechnology
IPO Date
2013-07-25
Stock Exchange
NASDAQ
Ticker
TRAW
According to Traws Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 489.90%. This represents a change of 47.02% compared to the average of 333.21% of the last 4 quarters.
The mean historical ROE of Traws Pharma, Inc. over the last ten years is -279.13%. The current 489.90% ROE has changed -275.51% with respect to the historical average. Over the past ten years (40 quarters), TRAW's ROE was at its highest in in the June 2017 quarter at 2.82%. The ROE was at its lowest in in the June 2016 quarter at -1037.06%.
Average
-279.13%
Median
-181.67%
Minimum
-1457.87%
Maximum
206.07%
Discovering the peaks and valleys of Traws Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 165.04%
Maximum Annual ROE = 206.07%
Minimum Annual Increase = -943.41%
Minimum Annual ROE = -1457.87%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1457.87% | -943.41% |
| 2024 | 172.85% | -197.36% |
| 2023 | -177.55% | 165.04% |
| 2022 | -66.99% | 91.15% |
| 2021 | -35.05% | -91.40% |
| 2020 | -407.40% | 119.28% |
| 2019 | -185.79% | -51.35% |
| 2018 | -381.90% | -285.32% |
| 2017 | 206.07% | -145.02% |
| 2016 | -457.69% | 91.06% |
The current ROE of Traws Pharma, Inc. (TRAW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-487.52%
5-year avg
-312.92%
10-year avg
-279.13%
Traws Pharma, Inc.’s ROE is greater than Cingulate Inc. (-365.16%), greater than Dogwood Therapeutics, Inc. (-35.91%), greater than Imunon, Inc. (-341.23%), greater than Cocrystal Pharma, Inc. (-150.61%), greater than Sensei Biotherapeutics, Inc. (-283.67%), greater than Bolt Biotherapeutics, Inc. (-100.90%), greater than Mustang Bio, Inc. (-35.38%), less than Evogene Ltd. (937.72%), greater than BioRestorative Therapies, Inc. (-423.84%), greater than Immuron Limited (-43.95%),
| Company | ROE | Market cap |
|---|---|---|
| -365.16% | $27.97M | |
| -35.91% | $2.96M | |
| -341.23% | $4.59M | |
| -150.61% | $10.20M | |
| -283.67% | $18.59M | |
| -100.90% | $7.67M | |
| -35.38% | $4.93M | |
| 937.72% | $4.52M | |
| -423.84% | $3.68M | |
| -43.95% | $6.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Traws Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Traws Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Traws Pharma, Inc.'s ROE?
How is the ROE calculated for Traws Pharma, Inc. (TRAW)?
What is the highest ROE for Traws Pharma, Inc. (TRAW)?
What is the 3-year average ROE for Traws Pharma, Inc. (TRAW)?
What is the 5-year average ROE for Traws Pharma, Inc. (TRAW)?
How does the current ROE for Traws Pharma, Inc. (TRAW) compare to its historical average?